サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1761163

細胞・遺伝子治療受託開発・製造機関の市場規模と予測 2021年～2031年、世界と地域のシェア、動向、成長機会分析レポート：サービスタイプ別、製品タイプ別、エンドユーザー別、地域別

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type, Product Type, End User, and Geography

出版日
ページ情報
英文 249 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.09円
細胞・遺伝子治療受託開発・製造機関の市場規模と予測 2021年～2031年、世界と地域のシェア、動向、成長機会分析レポート：サービスタイプ別、製品タイプ別、エンドユーザー別、地域別
出版日: 2025年06月05日
発行: The Insight Partners
ページ情報: 英文 249 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

弊社の最新調査レポート「細胞・遺伝子治療受託開発・製造機関の2031年までの市場予測-世界分析-サービスタイプ別、製品タイプ別、エンドユーザー別、地域別」によると、市場は2024年の62億2,000万米ドルから成長し、2031年には318億6,000万米ドルに達すると予測され、2025年から2031年にかけて26.4%のCAGRを記録すると予測されています。革新的な治療法の臨床試験の開拓、規制当局による承認と商業化の急増が、細胞・遺伝子治療の開発・製造受託機関市場規模の拡大に寄与しています。しかし、製造の複雑さが細胞・遺伝子治療受託開発・製造機関市場の成長を阻害しています。さらに、AIとデジタルトランスフォーメーションの統合の高まりは、今後数年間で新しい細胞・遺伝子治療受託開発・製造機関市場の動向をもたらすと予想されます。

収益面では、北米が2024年の市場を独占しました。予測期間中も世界市場を独占すると予測されます。米国は世界最大の細胞・遺伝子治療受託開発・製造機関市場です。米国では、バイオテクノロジーの進歩、遺伝性疾患の増加、専門的な製造サービスに対する需要の急増が観察されています。2021年10月に発表された米国政府説明責任局の推計によると、米国では2,500万人から3,000万人が希少疾患に苦しんでいます。食品医薬品局（FDA）によると、7,000以上の希少疾病が国内の3,000万人以上の人々に影響を及ぼしています。これらの疾患に対する理解が深まるにつれ、遺伝子治療開発が急増しています。CDMOは、希少遺伝性疾患を対象とした遺伝子治療の開発・製造に特化したサービスを提供することで、この分野で重要な役割を果たしています。

2023年、米国FDAは希少疾患をターゲットとした遺伝子編集治療を含む数多くの細胞・遺伝子治療を承認しました。鎌状赤血球症に対するexagamglogene autotemcel（Casgevy）やlovotibeglogene autotemcel、重症血友病Aに対するvaloctocogene roxaparvovecなどの治療薬がFDAの承認を得ており、希少疾患の課題に対する遺伝子治療の可能性を浮き彫りにしています。再生医療先進療法（RMAT）のような規制緩和の加速化により、バイオテクノロジー企業はCDMOと提携して生産を拡大する傾向にあります。

製造インフラへの投資が市場の成長を後押ししています。15の学術研究機関、25以上の企業、政府機関の協力により設立されたNational Cell Manufacturing Consortiumは、細胞治療の費用対効果に優れた大規模製造を可能にすることを目的としています。さらに、CDMO、学術機関、バイオ医薬品企業間の戦略的提携も市場成長に寄与しています。

細胞・遺伝子治療受託開発製造機関市場の分析

専門施設と技術へのアクセスが今後の市場機会をもたらす

細胞・遺伝子治療薬の需要は、バイオ医薬品企業を、品質、コンプライアンス、規制当局の承認を確保しながら生産を拡大するために必要な最先端の施設や技術を提供できるCDMOへと向かわせています。このような専門的能力は、高い製造基準を維持するために高度なインフラを必要とする、複雑で個別化された治療法の製造に不可欠です。遺伝子編集、ウイルスベクター生産、個別化医療を含む細胞・遺伝子治療には、最新技術を備えた専門施設が必要です。遺伝子治療に使用されるウイルスベクターの製造には、最終製品の安全性、一貫性、品質を確保するためにGMP基準の施設が必要です。これらの施設は、生きた細胞や遺伝子組み換え生物などの複雑な生物学的材料を、制御され監視された環境で取り扱うための設備を備えていなければならないです。自動化された細胞培養システム、連続製造、デジタル品質監視システムの採用が増加していることは、遺伝子治療生産の成長と効率を高めています。例えば、2025年3月、Bharat Biotech社はインド南部で初の細胞・遺伝子治療施設に7,500万米ドルを投資し、今後3年以内に腫瘍学と希少疾患向けの新しい治療法を発売する予定です。

専門施設の必要性は、CDMOにとって大きなチャンスです。バイオファーマ企業にとって、必要な技術や施設を持つCDMOと提携することは、費用対効果が高く効率的です。例えば、2023年、ブリストル・マイヤーズスクイブは、CAR-T細胞療法であるブリアンジの製造のためにCDMOと提携しました。この治療法は、患者のT細胞を採取、修正、拡大するもので、望ましい治療効果を確保するためには専門的な技術と設備を必要とするプロセスです。ブリストル・マイヤーズスクイブ社は、専門施設におけるCDMOの専門知識を活用することで、規制遵守と品質を確保しながら生産規模を拡大することができました。このように、先端技術を駆使した高度な製造能力に対するニーズの高まりは、細胞・遺伝子治療研究開発受託機関市場に将来の成長機会をもたらすと予想されます。

細胞・遺伝子治療受託開発・製造機関市場レポートセグメンテーション分析

細胞・遺伝子治療受託開発・製造機関市場分析の導出に寄与した主なセグメントは、サービスタイプ、製品タイプ、エンドユーザーです。

サービスタイプに基づき、細胞・遺伝子治療受託開発・製造機関市場は医薬品開発・製造、試験・規制サービス、その他に区分されます。医薬品開発・製造セグメントは2024年に市場で最大のシェアを占めました。

製品タイプ別では、細胞・遺伝子治療受託開発・製造機関市場は遺伝子治療と細胞治療に二分されます。2024年には細胞療法分野が市場を独占しました。

エンドユーザー別では、細胞・遺伝子治療受託開発・製造機関市場は製薬企業、バイオ製薬企業、その他に分類されます。2024年にはバイオ製薬企業セグメントが市場を独占しました。

細胞・遺伝子治療受託開発・製造機関市場：競合情勢と主な発展

WuXi Biologics Inc、Charles River Laboratories International Inc、Catalent Inc、Lonza Group AG、Thermo Fisher Scientific Inc、AGC Biologics AS、Takara Bio Inc、FUJIFILM Holdings Corp、Pluri Inc、SK pharmteco Inc、Aenova Holding GmbH、Minaris Advanced Therapiesなどが細胞・遺伝子治療受託開発・製造機関市場で事業を展開している主要企業です。

カナダ統計局（Statistics Canada）、世界人口展望（World Population Prospectus）、Globocan、ブラジル保健規制庁（ANVISA）、再生医療連合（ARM）、食品医薬品局（FDA）などは、細胞・遺伝子治療受託開発・製造機関市場レポートを作成する際に参照した一次情報源および二次情報源です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • アナリスト市場の展望

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • ファンデーション数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 細胞・遺伝子治療受託開発・製造機関市場情勢

  • 世界のプラスミド製造市場

第5章 細胞・遺伝子治療受託開発・製造機関市場：主な市場力学

  • 細胞・遺伝子治療受託開発・製造機関市場- 主な市場力学
  • 市場促進要因
    • 革新的治療のための臨床試験の増加
    • 規制当局による承認と商業化の急増
  • 市場抑制要因
    • 製造の複雑さ
  • 市場機会
    • 専門施設と技術へのアクセス
  • 今後の動向
    • AIとデジタルトランスフォーメーションの統合の高まり
  • 促進要因と抑制要因の影響

第6章 細胞・遺伝子治療受託開発・製造機関市場：世界市場分析

  • 細胞・遺伝子治療受託開発・製造機関市場の売上高、2021年～2031年
  • 細胞・遺伝子治療受託開発・製造機関市場予測分析

第7章 細胞・遺伝子治療受託開発・製造機関市場分析- サービスタイプ別

  • 医薬品開発と製造
  • 試験および薬事サービス
  • その他

第8章 細胞・遺伝子治療受託開発・製造機関の市場分析-製品タイプ別

  • 遺伝子治療
  • 細胞療法

第9章 細胞・遺伝子治療受託開発・製造機関市場分析-エンドユーザー別

  • 製薬会社
  • バイオ医薬品企業
  • その他

第10章 細胞・遺伝子治療受託開発・製造機関市場- 地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • アジア太平洋地域のその他諸国
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • その他中東とアフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第11章 競合情勢

  • 世界企業シェア分析、2024年

第12章 業界情勢

  • 事業拡大
  • 新製品開発
  • 合併と買収
  • パートナーシップ
  • その他の事業戦略

第13章 企業プロファイル

  • WuXi Biologics Inc
  • Charles River Laboratories International Inc
  • Catalent Inc
  • Lonza Group AG
  • Thermo Fisher Scientific Inc.
  • AGC Biologics AS
  • Takara Bio Inc
  • FUJIFILM Holdings Corp
  • Pluri Inc
  • SK pharmteco Inc
  • Aenova Holding GmbH
  • Minaris Advanced Therapies

第14章 付録

図表

List Of Tables

  • Table 1. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Segmentation
  • Table 2. Global Plasmid Manufacturing Market, US$ Million, 2021-2031
  • Table 3. Global Plasmid Manufacturing Market, By Type, 2021-2031 (US$ Million)
  • Table 4. Global Plasmid Manufacturing Market, By Application, 2021-2031 (US$ Million)
  • Table 5. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million)
  • Table 6. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million)
  • Table 7. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 8. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 9. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 10. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 11. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 12. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 13. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
  • Table 14. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 15. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
  • Table 16. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 17. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 18. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 19. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 20. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 21. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 22. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 23. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 24. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 25. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 26. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 27. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 28. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 29. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 30. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 31. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 32. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 33. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 34. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 35. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 36. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 37. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 38. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 39. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
  • Table 40. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 41. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
  • Table 42. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 43. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 44. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 45. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 46. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 47. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 48. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 49. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 50. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 51. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 52. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 53. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 54. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 55. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 56. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 57. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 58. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 59. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 60. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 61. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 62. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 63. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 64. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 65. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 66. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 67. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 68. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 69. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 70. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 71. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 72. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 73. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 74. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 75. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 76. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 77. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 78. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 79. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 80. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 81. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 82. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 83. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
  • Table 84. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 85. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
  • Table 86. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 87. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 88. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 89. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 90. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 91. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 92. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 93. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 94. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 95. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 96. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 97. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 98. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 99. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 100. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 101. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 102. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 103. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 104. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 105. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 106. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 107. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 108. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 109. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 110. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 111. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 112. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 113. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 114. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 115. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 116. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 117. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 118. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 119. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 120. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 121. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 122. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 123. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 124. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 125. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 126. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 127. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
  • Table 128. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 129. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
  • Table 130. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 131. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 132. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 133. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 134. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 135. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 136. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 137. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 138. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 139. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 140. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 141. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 142. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 143. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 144. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 145. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 146. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 147. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 148. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 149. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 150. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 151. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 152. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 153. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 154. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 155. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 156. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 157. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 158. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 159. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
  • Table 160. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 161. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
  • Table 162. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 163. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 164. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 165. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 166. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 167. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 168. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 169. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 170. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 171. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 172. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 173. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 174. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 175. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 176. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 177. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 178. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 179. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 180. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 181. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 182. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 183. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 184. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User

List Of Figures

  • Figure 1. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Revenue (US$ Million), 2021-2031
  • Figure 5. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Share (%) - by Service Type (2024 and 2031)
  • Figure 6. Drug Development and Manufacturing: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Testing and Regulatory Services: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Share (%) - by Product Type (2024 and 2031)
  • Figure 10. Gene Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Cell Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Share (%) - by End User (2024 and 2031)
  • Figure 13. Pharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Biopharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 17. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 18. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 19. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 20. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 21. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 22. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 23. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 24. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 25. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 26. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 27. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 28. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 29. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 30. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 31. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 32. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 33. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 34. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 35. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 36. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 37. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 38. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 39. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 40. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 41. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 42. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 43. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 44. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 45. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 46. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 47. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 48. Global Company Market Share Analysis, 2024
目次
Product Code: TIPRE00040769

According to our new research study on "Cell and Gene Therapy Contract Development and Manufacturing Organization Market Forecast to 2031 -Global Analysis - by Service Type, Product Type, End User, and Geography," the market is anticipated to grow from US$ 6.22 billion in 2024 and is projected to reach US$ 31.86 billion by 2031; it is expected to register a CAGR of 26.4% during 2025-2031. Increasing clinical trials for innovative therapies and surging regulatory approvals and commercialization are contributing to the growing cell and gene therapy contract development and manufacturing organization market size. However, the high manufacturing complexities hampers the cell and gene therapy contract development and manufacturing organization market growth. Further, rising integration of AI and digital transformation is expected to bring in new cell and gene therapy contract development and manufacturing organization market trends in the coming years.

In terms of revenue, North America dominated the market in 2024. It is estimated to dominate the global market during the forecast period. The US is the largest market for cell and gene therapy contract development and manufacturing organization in the world. The US is observing growing advancements in biotechnology, an increasing prevalence of genetic diseases, and surging demand for specialized manufacturing services. As per the estimates of the US Government Accountability Office published in October 2021, ~25 to 30 million people suffer from rare diseases in the country. As per the Food and Drug Administration (FDA), more than 7,000 rare diseases affect over 30 million people in the country. The growing understanding of these diseases has led to a surge in gene therapy development. CDMOs play a crucial role in this space by providing specialized services for the development and manufacturing of gene therapies targeting rare genetic disorders.

In 2023, the US FDA approved numerous cell and gene therapies, including gene-editing treatments targeting rare diseases. Therapies such as exagamglogene autotemcel (Casgevy) and lovotibeglogene autotemcel for sickle cell disease, as well as valoctocogene roxaparvovec for severe hemophilia A, have received FDA approval, highlighting the potential of gene therapies in addressing rare disease challenges. The accelerated regulatory pathways, such as the Regenerative Medicine Advanced Therapy (RMAT) designation, have spurred biotechnology companies to partner with CDMOs for scaling production.

Investments in manufacturing infrastructure have bolstered the market growth. The National Cell Manufacturing Consortium, established through collaboration between 15 academic institutes, over 25 companies, and government agencies, aims to enable cost-effective, large-scale manufacturing of cell therapies. In addition, strategic collaborations between CDMOs, academic institutions, and biopharma companies also contribute to market growth.

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Analysis

Access to Specialized Facilities and Technologies to Provide Market Opportunities in Future

The demand for cell and gene therapies is driving biopharmaceutical companies toward CDMOs that can provide cutting-edge facilities and technologies, which are required to scale up production while ensuring quality, compliance, and regulatory approval. These specialized capabilities are essential for the production of complex and personalized therapies, which require advanced infrastructure to maintain high manufacturing standards. Cell and gene therapies, including gene editing, viral vector production, and personalized medicine, require specialized facilities equipped with the latest technologies. The production of viral vectors used in gene therapies requires GMP standard facilities to ensure the safety, consistency, and quality of the final product. These facilities should be equipped to handle complex biological materials, such as live cells and genetically modified organisms, in controlled and monitored environments. The increasing adoption of automated cell culture systems, continuous manufacturing, and digital quality monitoring systems enhances the growth and efficiency of gene therapy production. For instance, in March 2025, Bharat Biotech invested US$ 75 million in its first cell and gene therapy facility in the southern India which is expected to launch new therapies in next 3 years for oncology and rare disease.

The need for specialized facilities creates a substantial opportunity for CDMOs. It is cost-effective and efficient for biopharma companies to collaborate with CDMOs that have the required technology and facilities. For instance, in 2023, Bristol-Myers Squibb collaborated with a CDMO for the production of its CAR-T cell therapy, Breyanzi. This therapy involves harvesting, modifying, and expanding a patient's T-cells, a process requiring specialized technology and facilities to ensure the desired therapeutic effect. By leveraging CDMO expertise in specialized facilities, Bristol-Myers Squibb was able to scale production while ensuring regulatory compliance and quality. Thus, the soaring need for advanced manufacturing capabilities with advanced technology is expected to create future growth opportunities for the cell and gene therapy contract research and development organization market.

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Report Segmentation Analysis

Key segments that contributed to the derivation of the cell and gene therapy contract development and manufacturing organization market analysis are service type, product type, and end user.

Based on service type, the cell and gene therapy contract development and manufacturing organization market is segmented into drug development and manufacturing, testing and regulatory services, and others. The drug development and manufacturing segment held the largest share of the market in 2024.

In terms of product type, the cell and gene therapy contract development and manufacturing organization market is bifurcated into gene therapy and cell therapy. The cell therapy segment dominated the market in 2024.

By end user, the cell and gene therapy contract development and manufacturing organization market is categorized into pharmaceutical companies, biopharmaceutical companies, and others. The biopharmaceutical companies segment dominated the market in 2024.

Cell and Gene Therapy Contract Development and Manufacturing Organization Market: Competitive Landscape and Key Developments

WuXi Biologics Inc, Charles River Laboratories International Inc, Catalent Inc, Lonza Group AG, Thermo Fisher Scientific Inc., AGC Biologics AS, Takara Bio Inc, FUJIFILM Holdings Corp, Pluri Inc, SK pharmteco Inc, Aenova Holding GmbH, and Minaris Advanced Therapies are among the key companies operating in the cell and gene therapy contract development and manufacturing organization market.

Statistics Canada, World Population Prospectus, Globocan, Brazilian Health Regulatory Agency (ANVISA), Alliance for Regenerative Medicine (ARM), and the Food and Drug Administration (FDA) are among the primary and secondary sources referred to while preparing the cell and gene therapy contract development and manufacturing organization market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Landscape

  • 4.1 Overview
  • 4.2 Global Plasmid Manufacturing Market

5. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Key Market Dynamics

  • 5.1 Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Clinical Trials for Innovative Therapies
    • 5.2.2 Surging Regulatory Approvals and Commercialization
  • 5.3 Market Restraints
    • 5.3.1 High Manufacturing Complexities
  • 5.4 Market Opportunities
    • 5.4.1 Access to Specialized Facilities and Technologies
  • 5.5 Future Trends
    • 5.5.1 Rising Integration of AI and Digital Transformation
  • 5.6 Impact of Drivers and Restraints:

6. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Global Market Analysis

  • 6.1 Cell And Gene Therapy Contract Development and Manufacturing Organization Market Revenue (US$ Million), 2021-2031
  • 6.2 Cell And Gene Therapy Contract Development and Manufacturing Organization Market Forecast Analysis

7. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Analysis - by Service Type

  • 7.1 Drug Development and Manufacturing
    • 7.1.1 Overview
    • 7.1.2 Drug Development and Manufacturing: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Testing and Regulatory Services
    • 7.2.1 Overview
    • 7.2.2 Testing and Regulatory Services: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Others
    • 7.3.1 Overview
    • 7.3.2 Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)

8. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Analysis - by Product Type

  • 8.1 Gene Therapy
    • 8.1.1 Overview
    • 8.1.2 Gene Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Cell Therapy
    • 8.2.1 Overview
    • 8.2.2 Cell Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)

9. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Analysis - by End User

  • 9.1 Pharmaceutical Companies
    • 9.1.1 Overview
    • 9.1.2 Pharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Biopharmaceutical Companies
    • 9.2.1 Overview
    • 9.2.2 Biopharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)

10. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
    • 10.2.2 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
      • 10.2.2.1 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
      • 10.2.2.2 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
      • 10.2.2.3 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
    • 10.2.3 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.2.3.1 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.2.3.2 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.2.3.2.1 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.2.3.2.2 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.2.3.2.3 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.2.3.3 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.2.3.3.1 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.2.3.3.2 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.2.3.3.3 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.2.3.4 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.2.3.4.1 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.2.3.4.2 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.2.3.4.3 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
  • 10.3 Europe
    • 10.3.1 Europe Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
    • 10.3.2 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
      • 10.3.2.1 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
      • 10.3.2.2 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
      • 10.3.2.3 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
    • 10.3.3 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.3.3.1 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.3.3.2 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.2.1 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.2.2 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.2.3 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.3.3.3 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.3.1 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.3.2 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.3.3 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.3.3.4 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.4.1 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.4.2 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.4.3 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.3.3.5 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.5.1 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.5.2 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.5.3 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.3.3.6 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.6.1 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.6.2 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.6.3 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.3.3.7 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.7.1 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.7.2 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.7.3 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
    • 10.4.2 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
      • 10.4.2.1 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
      • 10.4.2.2 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
      • 10.4.2.3 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
    • 10.4.3 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.4.3.1 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.4.3.2 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.2.1 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.2.2 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.2.3 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.4.3.3 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.3.1 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.3.2 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.3.3 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.4.3.4 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.4.1 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.4.2 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.4.3 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.4.3.5 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.5.1 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.5.2 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.5.3 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.4.3.6 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.6.1 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.6.2 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.6.3 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.4.3.7 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.7.1 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.7.2 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.7.3 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
    • 10.5.2 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
      • 10.5.2.1 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
      • 10.5.2.2 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
      • 10.5.2.3 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
    • 10.5.3 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.5.3.1 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.5.3.2 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.5.3.2.1 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.5.3.2.2 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.5.3.2.3 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.5.3.3 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.5.3.3.1 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.5.3.3.2 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.5.3.3.3 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.5.3.4 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.5.3.4.1 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.5.3.4.2 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.5.3.4.3 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.5.3.5 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.5.3.5.1 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.5.3.5.2 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.5.3.5.3 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
  • 10.6 South and Central America
    • 10.6.1 South and Central America Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
    • 10.6.2 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
      • 10.6.2.1 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
      • 10.6.2.2 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
      • 10.6.2.3 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
      • 10.6.2.4 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.6.2.5 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.6.2.5.1 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.6.2.5.2 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.6.2.5.3 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.6.2.6 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.6.2.6.1 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.6.2.6.2 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.6.2.6.3 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.6.2.7 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.6.2.7.1 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.6.2.7.2 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.6.2.7.3 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User

11. Competitive Landscape

  • 11.1 Global Company Market Share Analysis, 2024

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Expansion
  • 12.3 New Product Development
  • 12.4 Merger and Acquisition
  • 12.5 Partnerships
  • 12.6 Other Business Strategies

13. Company Profiles

  • 13.1 WuXi Biologics Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Charles River Laboratories International Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Catalent Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Lonza Group AG
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Thermo Fisher Scientific Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 AGC Biologics AS
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Takara Bio Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 FUJIFILM Holdings Corp
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Pluri Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 SK pharmteco Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Aenova Holding GmbH
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Minaris Advanced Therapies
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments

14. Appendix

  • 14.1 Glossary of Terms
  • 14.2 About The Insight Partners